Vivos Therapeutics Statistics
NASDAQ: VVOSHealthcareMedical DevicesUSD
0.1495-0.0015 (-0.99%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Vivos Therapeutics by the numbers
Vivos Therapeutics has a market capitalization of $5.0 million based on 33.61M shares outstanding. With trailing EPS of $-1.88, Vivos Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 35.2% below its 50-day average and 83.5% below its 200-day average.
Average daily trading volume is 12.57M shares, or about $1.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VVOS valuation vs. peer median
| Metric | VVOS | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.02M | $5.06M | -1% |
| Avg. volume | 12.57M | 148.88K | +8346% |
Peer median across 8 companies: INBS, TRIB, ICCM, AIDX, POAS, NVNO, AMIX, BJDX.
Valuation
- Market cap
- $5.02M
- EPS (TTM)
- $-1.88
- Shares outstanding
- 33.61M
Price and trading
- Previous close
- 0.151
- Open
- 0.151
- Day range
- 0.146 – 0.1536
- 52-week range
- 0.129 – 3.28
- 50-day moving average
- 0.2306
- 200-day moving average
- 0.9041
- Beta
- —
- Volume
- 584.20K
- Average volume
- 12.57M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2026
Additional statistics
- Market Cap
- 5.02M
- Forward Pe
- -0.18
- Eps
- -1.88
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.28
- Week52 Low
- 0.13
- Avg Volume
- 12.57M
- Shares Outstanding
- 33.61M
- Ma50
- 0.23
- Ma200
- 0.90
- Earnings Date
- Aug 14, 2026
- Pct From52w High
- -95.44%
- Pct From52w Low
- 15.89%